↓ Skip to main content

The Prospective Role of Plant Products in Radiotherapy of Cancer: A Current Overview

Overview of attention for article published in Frontiers in Pharmacology, January 2012
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (64th percentile)

Mentioned by

twitter
2 X users
peer_reviews
1 peer review site
facebook
3 Facebook pages
video
1 YouTube creator

Citations

dimensions_citation
51 Dimensions

Readers on

mendeley
104 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The Prospective Role of Plant Products in Radiotherapy of Cancer: A Current Overview
Published in
Frontiers in Pharmacology, January 2012
DOI 10.3389/fphar.2011.00094
Pubmed ID
Authors

Banasri Hazra, Subhalakshmi Ghosh, Amit Kumar, B. N. Pandey

Abstract

Treatment of cancer often requires exposure to radiation, which has several limitations involving non-specific toxicity toward normal cells, reducing the efficacy of treatment. Efforts are going on to find chemical compounds which would effectively offer protection to the normal tissues after radiation exposure during radiotherapy of cancer. In this regard, plant-derived compounds might serve as "leads" to design ideal radioprotectors/radiosensitizers. This article reviews some of the recent findings on prospective medicinal plants, phytochemicals, and their analogs, based on both in vitro and in vivo tumor models especially focused with relevance to cancer radiotherapy. Also, pertinent discussion has been presented on the molecular mechanism of apoptotic death in relation to the oxidative stress in cancer cells induced by some of these plant samples and their active constituents.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 104 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Lebanon 1 <1%
United States 1 <1%
Unknown 102 98%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 20 19%
Researcher 16 15%
Student > Master 13 13%
Student > Bachelor 6 6%
Other 6 6%
Other 17 16%
Unknown 26 25%
Readers by discipline Count As %
Agricultural and Biological Sciences 21 20%
Medicine and Dentistry 15 14%
Biochemistry, Genetics and Molecular Biology 15 14%
Pharmacology, Toxicology and Pharmaceutical Science 8 8%
Chemistry 4 4%
Other 7 7%
Unknown 34 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 November 2019.
All research outputs
#12,660,755
of 22,663,150 outputs
Outputs from Frontiers in Pharmacology
#3,381
of 15,822 outputs
Outputs of similar age
#141,645
of 244,048 outputs
Outputs of similar age from Frontiers in Pharmacology
#49
of 137 outputs
Altmetric has tracked 22,663,150 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 15,822 research outputs from this source. They receive a mean Attention Score of 4.9. This one has done well, scoring higher than 78% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 244,048 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 41st percentile – i.e., 41% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 137 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 64% of its contemporaries.